Print Page | Contact Us | Sign In | JOIN FPA
Online Store: Continuing Education Home Study Programs
Main Storefront

Management of Asthma

Item Options
Sign in for your pricing!
Price: $95.00
Quantity: *

Management of Asthma

Once purchased the link emailed to you is valid for 60 days. If you do not complete the course within 60 days call the FPA office and we will resend the link to complete the course. 

FPA Correspondence Course
Approved for Florida Consultant Recertification
3 Contact Hours or 0.3 CEU's


Asthma is a chronic disease that inflames and narrows the airways of the lungs.  There are variable and recurring symptoms, reversible airflow obstruction and bronchospasm.  Symptoms includes wheezing, coughing, chest tightness and shortness of breath. Asthma is caused by a combination of genetic and environmental factors.

Worldwide in 2015, 358 million people had asthma. There is no cure for asthma, and the rates of asthma have increased significantly.  Approximately 300,000 people die per year from the disease.  Mortality has decreased over the last few decades due to better recognition of the disease and improvement of care.


At the completion of this home study activity, pharmacists will be able to: Define asthma; Explain the epidemiology and etiology of asthma; Identify agents that trigger asthma; Explain the pathophysiology of asthma; Identify the signs and symptoms associated with asthma; Identify various medications used to treat asthma; Compare and contrast different asthma inhalers; Identify the role of the pharmacist in the management of asthma.


Florida Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Three (3) contact hours are available upon completion of the posttest questions and evaluation form.  You must pass the exam with a score of 70% or better.   This is an ACPE knowledge-based activity.  Initial Release Date: June 1, 2018.  Expiration Date:   June 1, 2021. UAN:  0165-0000-18-061-H01-P. Florida Board of Pharmacy approval number 20-622031.